LMT: Q2 Margin Collapse Beneath the Boom

Lockheed trades at a 29.21 PE on trailing EPS of $21.48. Strip out Q2's anomalous $1.46 and normalize to the $6-7 quarterly run rate seen in Q1, Q3, and Q4 — trailing earnings would be north of $26, implying a sub-25x multiple. But you cannot strip out quarters selectively. Q2 happened. It cost $342 million in net income against $18.16 billion in revenue. That is a 1.9% net margin.

The P/B of 16.62 is the more alarming figure. Book value is $29.11 per share. The stock is at $627.43. That premium is sustained entirely by earnings power — and earnings power just demonstrated it can crater in a single quarter.

Debt-to-equity sits at 3.23. That is not unusual for defense primes, but it amplifies the P/B story: the balance sheet is leveraged, so book value understates true risk. Interest coverage of 8.04x is adequate, not comfortable. A program charge cycle of the Q2 variety, repeated, would compress coverage fast.

The balance sheet tells a leverage story. Debt-to-equity of 3.23 means Lockheed finances its operations heavily with debt rather than equity. That works when margins are stable and cash flow is predictable. Q2 demonstrated that neither is guaranteed.

Free cash flow per share by quarter: Q1 $4.07, Q2 -$0.64, Q3 $14.43, Q4 $11.94. The Q3 and Q4 FCF numbers are genuinely strong — $14.43 and $11.94 per share in two quarters alone more than offset the Q2 deficit. Full-year FCF generation supports the dividend and buyback program.

The issue is sequencing. In a leveraged balance sheet with 3.23x debt-to-equity, a quarter of negative FCF and 4% gross margins does not break the company — interest coverage at 8.04x confirms that — but it does reveal that program execution risk is real, not theoretical. CIBC reduced its stake by 11.6% in the period covered by this data. That is one institutional signal worth registering.

The Greece €4 billion Achilles Shield deal is the headline catalyst. Lockheed's positioning relative to peers is covered in our defense sector comparison. It covers air and missile defense systems — Lockheed's core competency in THAAD and Patriot-adjacent platforms. European defense spending as a share of GDP is rising across NATO members under political pressure that did not exist two years ago.

Analyst consensus estimates for 2028 put revenue at $24.49 billion per year and EPS at $10.03 per year. Wait — those figures look like quarterly run-rate numbers misattributed as annual. Taking the 2028 EPS estimate at face value against the current $627.43 price implies roughly 62x forward earnings on that figure, which is implausible for a defense prime. The more likely read: consensus 2028 annual EPS is in the $28-30 range based on the $21.48 trailing base plus low-to-mid single digit annual growth.

The Achilles Shield deal adds backlog. Backlog converts to revenue over multi-year delivery schedules. The risk is that large international programs are precisely where charge risk resides — cost overruns on fixed-price contracts, foreign exchange exposure, and delivery schedule slippage are the mechanisms that produced Q2 2025's margin collapse. New international deals are growth, yes. They are also the source of the next potential program charge.